tiprankstipranks
Profound Medical (PROF)
NASDAQ:PROF
US Market
PROF
Profound Medical
RESEARCH TOOLSreports

Profound Medical (PROF) Financial Statements

80 Followers

Profound Medical Financial Overview

Profound Medical's market cap is currently $249.89M. The company's EPS TTM is $-1.24; its P/E ratio is -5.54; Profound Medical is scheduled to report earnings on May 7, 2026, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 16.38M$ 10.68M$ 7.20M$ 6.68M$ 6.87M
Gross Profit$ 11.59M$ 7.04M$ 4.38M$ 3.02M$ 2.95M
Operating Income$ -41.98M$ -33.06M$ -28.62M$ -29.60M$ -30.29M
EBITDA$ -41.41M$ -32.13M$ -27.00M$ -26.60M$ -28.65M
Net Income$ -43.32M$ -27.82M$ -28.57M$ -28.67M$ -30.70M
Balance Sheet
Cash & Short-Term Investments$ 59.61M$ 54.91M$ 26.21M$ 46.94M$ 66.59M
Total Assets$ 140.62M$ 70.23M$ 43.91M$ 64.42M$ 86.78M
Total Debt$ 4.70M$ 5.12M$ 7.87M$ 8.30M$ 1.38M
Net Debt$ -54.91M$ -49.79M$ -18.35M$ -38.29M$ -65.78M
Total Liabilities$ 74.30M$ 9.81M$ 12.73M$ 12.42M$ 6.16M
Stockholders' Equity$ 66.31M$ 60.42M$ 31.18M$ 52.48M$ 79.95M
Cash Flow
Free Cash Flow$ -39.05M$ -23.45M$ -22.30M$ -25.80M$ -22.95M
Operating Cash Flow$ -38.88M$ -23.45M$ -22.61M$ -25.80M$ -22.36M
Investing Cash Flow$ -246.24K$ 0.00$ 0.00$ 0.00$ -583.04K
Financing Cash Flow$ 41.86M$ 54.70M$ 1.76M$ 7.03M$ 5.95M
Currency in USD

Profound Medical Earnings and Revenue History

Income Statement >

Profound Medical Debt to Assets

Balance Sheet >

Profound Medical Cash Flow

Cash Flow >

Profound Medical Forecast EPS vs Actual EPS

Earnings >